Azenta Obtains Regulatory Approval for Clinical Long-Read Whole Genome Sequencing Test
Press Releases
Azenta  
October 30, 2024

Azenta Obtains Regulatory Approval for Clinical Long-Read Whole Genome Sequencing Test

BURLINGTON, Mass., Oct. 30, 2024 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today announced the launch of a long-read Whole Genome Sequencing (WGS) test for clinical applications. Azenta becomes the first

avatar profile Olean Times Herald

Olean Times Herald


Local & Social